In addition to these studies demonstrating the role of HER2/neu in gynecological cancers, Zhang et al. reported that overproduction of HTATIP2/TIP30 is associated with HER2/neu status in breast cancer [10]. This evidence concerns the gene ERBB2 and breast carcinoma.